New Clinical Trial to Test Effectiveness of Vorinostat (Zolinza) on Malignant Pleural Mesothelioma.
A phase III clinical trial is underway, in Maryland, at the National Institutes of Health Clinical Center, to determine how effective vorinostat is at treating patients with pleural malignant mesothelioma...
Experimental Mesothelioma Treatment Tested in Clinical Trial at New York's Columbia Presbyterian Hospital
New York’s Columbia Presbyterian Hospital is hosting a mesothelioma clinical trial...
Mesothelioma Clinical Trial in New York City Tests Cisplatin, Pemetrexed, and Bevacizumab
Researchers at Columbia Presbyterian Hospital are currently conducting a mesothelioma clinical trial in New York City to determine if a new experimental treatment for mesothelioma is effective and safe. Patients enrolled in this study will be adminis...
Phase I Trial Looks at Vaccine Therapy and GM-CSF as a New Mesothelioma Treatment for Patients with Mesothelioma and Other Cancers
A Phase I study has been initiated by mesothelioma research doctors...
Mesothelioma Clinic Researches Drug PXD101 in Phase II Trial as a Second-Line Mesothelioma Treatment
Researchers in California and Pennsylvania are conducting a clinical trial in mesothelioma research clinics to see if the drug PXD101 offers an effective form of treatment for mesothelioma patients. It is hypothesized that PXD101 may disrupt blood fl...
Phase II Trial Combines Traditional Mesothelioma Treatments with Avastin and Tarceva to Determine if this New Mesothelioma Treatment Helps Patients Who Have Been Diagnosed with Mesothelioma
The University of Chicago and Massachusetts General Hospital are sponsoring a study to see if patients who have been diagnosed with mesothelioma and have undergone traditional mesothelioma treatments...
Phase II Research Trial on Malignant Mesothelioma Seeks to Determine if the Cancer Treatment Drug AZD2171 Can Halt Tumor Growth in Patients with Mesothelioma
A clinical trial is underway to determine if the cancer treatment drug AZD2171 can interrupt blood flow to tumors and deter some of the enzymes required for cell growth in the tumors of patients with malignant mesothelioma...
Clinical Trial Seeks to Determine if Low-Dose Computed Tomography (LDCT) Can Be Used as a Mesothelioma Test to Detect the Presence of Mesothelioma Before Clinical Symptoms Appear
Mesothelioma tests...
Phase II Research Trial Seeks to Compare Different Chemotherapy Regimens to Find a New Mesothelioma Treatment
A Phase II trial for the purpose of finding a new mesothelioma treatment is underway. The trial aims to determine if pemetrexed disodium plus gemcitabine is a more effective way of treating patients with malignant pleural mesothelioma...
Potential New Mesothelioma Treatment, Gene Therapy Drug BG00001, Set to Begin Phase 1 Trial at Mesothelioma Research Clinic
A potential new mesothelioma treatment begins its phase 1 clinical trial at one of the most prestigious mesothelioma research clinics...
Malignant Mesothelioma Research: Phase I Trial of INNO-305 Underway
Malignant mesothelioma research...
Cancer Research Study Collects Tissue Samples in an Effort to Devise New Forms of Radiation Therapy
A Phase II trial for the purpose of finding a new mesothelioma treatment is underway. The trial aims to determine if pemetrexed disodium plus gemcitabine is a more effective way of treating patients with malignant pleural mesothelioma...
Phase 1 Study Seeks to Determine if Cancer Treatment Drugs, Romidepsin Plus Flavopiridol, Can Promote Cell Death in Cancer Cells
Clinical trials for Romidepsin plus Flavopiridol could advance clinic research in mesothelioma treatments.
A Phase 1 study is currently underway to determine if the cancer treatment drug Romidepsin when combined with the drug Flavopiridol have...
A Potential Mesothelioma Cancer Treatment Drug Shows Promise for the Shrinking of Tumors
In the September 11, 2004, edition of The Daily Telegraph ...
